High serum carbohydrate antigen-125 (CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F12%3A33140217" target="_blank" >RIV/61989592:15110/12:33140217 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1007/s12185-012-1102-1" target="_blank" >http://dx.doi.org/10.1007/s12185-012-1102-1</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12185-012-1102-1" target="_blank" >10.1007/s12185-012-1102-1</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
High serum carbohydrate antigen-125 (CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score
Popis výsledku v původním jazyce
Carbohydrate antigen-125 (CA-125) was established as a prognostic marker in cancer, especially in ovarian carcinoma. Many recent studies have also reported on the prognostic significance of CA-125 in patients with different types of lymphoma, but only afew studies have been carried out in patients treated with rituximab or high-dose therapy. The prognostic impact of CA-125 on a large cohort of patients with follicular lymphoma (FL) has not been studied. This study analyzed the prognostic significance of CA-125 levels in 116 prospectively enrolled patients with previously untreated FL. It showed that the CA-125 level at the time of treatment initiation correlates with the clinical stage, number of involved nodal areas, bulky disease, hemoglobin level,beta-2 microglobulin level, and lactate dehydrogenase level. Patients with CA-125 }35 U/mL had significantly shorter progression-free (p { 0.001) and overall (p = 0.025) survival rates. Cox regression analysis identified high CA-125 level
Název v anglickém jazyce
High serum carbohydrate antigen-125 (CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score
Popis výsledku anglicky
Carbohydrate antigen-125 (CA-125) was established as a prognostic marker in cancer, especially in ovarian carcinoma. Many recent studies have also reported on the prognostic significance of CA-125 in patients with different types of lymphoma, but only afew studies have been carried out in patients treated with rituximab or high-dose therapy. The prognostic impact of CA-125 on a large cohort of patients with follicular lymphoma (FL) has not been studied. This study analyzed the prognostic significance of CA-125 levels in 116 prospectively enrolled patients with previously untreated FL. It showed that the CA-125 level at the time of treatment initiation correlates with the clinical stage, number of involved nodal areas, bulky disease, hemoglobin level,beta-2 microglobulin level, and lactate dehydrogenase level. Patients with CA-125 }35 U/mL had significantly shorter progression-free (p { 0.001) and overall (p = 0.025) survival rates. Cox regression analysis identified high CA-125 level
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of Hematology
ISSN
0925-5710
e-ISSN
—
Svazek periodika
96
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
JP - Japonsko
Počet stran výsledku
7
Strana od-do
58-64
Kód UT WoS článku
—
EID výsledku v databázi Scopus
—